Search

everythinglearnresearchcommunity

for

Search:↓

Adding a small amount of TPGS to minoxidil can help hair growth, but too much TPGS reduces this effect and increases minoxidil in the blood.

SLE significantly affects daily life, especially through fatigue and joint pain, highlighting the need for better treatments.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

New drug delivery methods can make natural compounds more effective and stable.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

The emulgel with 11.5% oil and 1.75% gelling agent effectively delivers fluconazole topically with improved spreadability and stability.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

The skin is a complex barrier for drug penetration, but understanding its structure and interactions can improve drug delivery methods.

Pig skin is a good substitute for human skin to measure drug absorption, but differences in skin structure and enzymes across species must be considered.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Some medications can cause acne, and stopping these drugs is the main treatment.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Transdermal drug delivery systems are effective and promising for future use.